Simon Ward
2 presentations
-
DT-101 – A NOVEL ALPHA-AMINO-3-HYDROXY-5-METHYL-4-ISOXAZOLE RECEPTOR (AMPAR) POSITIVE ALLOSTERIC MODULATOR DEMONSTRATES FAVORABLE TOLERABILITY AND FUNCTIONAL BIOMARKERS IN PHASE 1 HEALTHY VOLUNTEER TRIAL
-
T65. DT-101 – A NOVEL ALPHA-AMINO-3-HYDROXY-5-METHYL-4-ISOXAZOLE RECEPTOR (AMPAR) POSITIVE ALLOSTERIC MODULATOR DEMONSTRATES FAVORABLE TOLERABILITY AND FUNCTIONAL BIOMARKERS IN PHASE 1 HEALTHY VOLUNTEER TRIAL